The latest news, trends, analysis, interviews and podcasts from the global food and beverage industry

A2 Milk Company Limited has acquired a nutritional manufacturing facility in New Zealand for NZ 282 million ($168 million), a move aimed at expanding its footprint in the lucrative Chinese market.

This facility, previously owned by a unit of China Mengniu Dairy, already holds two existing product registrations for the Chinese market, positioning A2 Milk to enhance its operational capabilities and product offerings.

The acquisition is part of A2 Milk's broader strategy to increase its market share in China, which remains its top revenue-generating region.

The company views this facility as a critical asset that will enable it to capitalise on the growing demand for infant milk formula products in Asia.

By securing local manufacturing capabilities, A2 Milk aims to streamline its supply chain and improve its responsiveness to market trends.

In conjunction with this acquisition, A2 Milk plans to divest its 75% stake in Mataura Valley Milk for approximately NZ 100 million. This divestiture is expected to help fund the facility purchase and aligns with A2 Milk’s focus on core business areas.

The acquisition reflects a strategic investment in A2 Milk’s future growth, particularly as the company seeks to navigate the competitive landscape of the infant nutrition sector.

With the New Zealand facility now part of its operations, A2 Milk is well-positioned to leverage its existing product registrations and enhance its offerings in the rapidly expanding China label infant formula market.